General University Hospital of Patras

Patras, Greece

We welcome General University Hospital of Patras in Greece as an Enrolled Centre in the IASIOS community. This enrolment reflects a clear commitment to quality, structure, and continuous improvement in interventional oncology through the IASIOS accreditation pathway.

We look forward to supporting their team as they advance through the accreditation process.

Dr. Konstantinos Katsanos

IASIOS Council Member

(Patras University Hospital, Greece)

Fondazione Policlinico Universitario Campus Bio-Medico

Rome, Italy

We are delighted to announce that Fondazione Policlinico Universitario Campus Bio-Medico from Italy has become an IASIOS Accredited Centre. This confirms that the hospital’s interventional oncology service line meets the highest international standards of standardisation and quality. Under the leadership of Prof. Rosario Francesco Grasso, the team has demonstrated a strong commitment to providing safe, consistent, and patient-centred care while pursuing continuous improvement.

The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital

Amsterdam, Netherlands

We are proud to announce that The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital has achieved the status of IASIOS Accredited Centre. This achievement demonstrates that its interventional oncology service fulfils the core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology. Led by Dr. Tarik Baetens, the team has displayed strong dedication to delivering structured, patient-focused care and maintaining continuous quality improvement. We congratulate them on this important milestone.

University Hospital Tübingen

Tübingen, Germany

We are pleased to welcome University Hospital Tübingen – Diagnostic and Interventional Radiology as a new IASIOS Enrolled Centre in Germany. This step reflects the team’s commitment to strengthening quality and consistency in interventional oncology through a structured accreditation framework. We look forward to supporting the team as they progress toward IASIOS accreditation.

Baptist Health Miami Cancer Institute

Miami, Florida

We proudly welcome Baptist Health Miami Cancer Institute as an Enrolled Centre. Under the leadership of Dr. Govindarajan Narayanan, this step reflects their dedication to delivering high-quality, multidisciplinary cancer care and advancing the field of interventional oncology. We are glad to see the IASIOS presence expand in North America and look forward to supporting the team as they progress through the accreditation pathway.

SLK Kliniken Heilbronn GmbH

Heilbronn, Germany

We are proud to announce that SLK Kliniken Heilbronn in Germany has been recognized as an IASIOS Centre of Excellence, becoming the third centre worldwide and the very first in Germany to achieve this distinction.

The Centre of Excellence designation is the highest level of recognition within IASIOS, confirming that SLK Kliniken Heilbronn fulfils both the core and extended criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology. This recognition means that the entire interventional oncology patient pathway at the centre follows a systematic and structured approach, where every patient receives consistent and high-quality care. Staff competence, advanced facility infrastructure, precise treatment delivery, and rigorous standards of radiation safety are all upheld at the highest international level.

We commend the dedication and commitment of Prof. Pereira, Prof. Grözinger, Dr. Speck, Dr. Mayer, Mr. Hermann, Dr. Wandschneider and the entire interventional radiology team at SLK Kliniken Heilbronn. Their achievement represents an outstanding contribution to clinical quality in interventional oncology and serves as an inspiration to the global IO community.

Dr. Sina Speck

IASIOS Council Member

(SLK-Kliniken Heilbronn, Germany)

Amsterdam UMC

Nijmegen, Netherlands

We are proud to share that Amsterdam UMC in the Netherlands has been recognised as an IASIOS Accredited Centre. This achievement confirms that its interventional oncology service line meets all core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.

Under the leadership of Prof. Martijn Meijerink, the team has shown a clear dedication to safety, quality, and patient-centred care in interventional oncology.

Prof. Martijn Meijerink

IASIOS Council Member

(Amsterdam University Medical Centre, Netherlands)

Charité Universitätsmedizin Berlin

Berlin, Germany

Congratulations to Charité Universitätsmedizin Berlin in Germany on becoming an IASIOS Accredited Centre. This achievement affirms that their interventional oncology service adheres to the international standards of quality and safety. Under the leadership of Prof. Dr. Bernhard Gebauer, the team has demonstrated a strong commitment to structured, patient-centered care and continuous quality improvement. We value their dedication to this milestone and look forward to their continued success within the IASIOS community.

Hunter New England Medical Imaging

New Lambton Heights, Australia

John Hunter Hospital, part of the Hunter New England Medical Imaging network

We are delighted to share that Hunter New England Medical Imaging in New Lambton Heights, Australia, has joined IASIOS as an Enrolled Centre. Under the leadership of Dr. Christian Abel, the team is taking an important step towards strengthening quality in interventional oncology.

We look forward to supporting them on their accreditation journey.

National Institutes of Health

Bethesda, Maryland

We are pleased to announce that the National Institutes of Health (NIH) in Bethesda, Maryland, has become an IASIOS Accredited Centre.This recognition confirms that its interventional oncology service line meets all core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.

Led by Dr Brad Wood, the accreditation reflects the team’s outstanding commitment to quality, safety, and standardisation in patient care.
As a leader in medical research and healthcare, NIH sets an important example by aligning world-class expertise with internationally standardised pathways in interventional oncology.

We extend our warmest congratulations to Dr Wood and the entire team for this outstanding achievement.